GE Healthcare is preparing for its spinoff from GE, which is planned for the first week of January. The company's split will allow it to operate under a new board, as well as manage its own capital. That capital will be primarily invested in acquisitions and research and development efforts, according to GE Healthcare's CEO for the U.S. and Canada.
Hospitals struggle to retain switchboard and call center staff, a situation exacerbated by inflation. Here's how Parlance is leveraging its call automation tech to help address these needs and improve the caller experience.
By Ventech Solutions and MedCity News Friday, October 28, 2022 7:30 AM
Learn how planning for the strategic use of a low-code platform helps provide long-term benefits and helps to avoid issues resulting from suboptimal use of the products.
By Frank Vinluan Thursday, October 27, 2022 7:05 PM
Agios Pharmaceuticals sold royalties to an approved cancer drug to get immediate cash to support its new focus on rare diseases. Earlier this year, the FDA approved the biotech's first rare disease drug, a treatment for a type of anemia.
By Marissa Plescia Thursday, October 27, 2022 6:51 PM
Latino and Black communities saw the largest increase in Marketplace enrollment. HHS credited the rise partially to improved outreach and education efforts.
By Arundhati Parmar Thursday, October 27, 2022 6:27 PM
In this episode, we are conversing with Sonia Millsom, CEO of executive search firm Oxeon, to discuss trends shaping the marketplace following the Great Resignation as well as how Oxeon is spurring innovation through its venture studio.
Motto is the latest startup built by Redesign Health. The startup is virtual care platform that is now available for Californians and Texans with autoimmune and chronic inflammatory conditions. It seeks to increase access to care by offering virtual appointments with rheumatologists, condition management services and lifestyle coaching on its telehealth platform.
By Marissa Plescia Thursday, October 27, 2022 2:50 PM
HealthJoy has raised more than $108 million total. This funding round was led by Valspring Capital, while other investors of the company include Endeavour Vision, CIBC Innovation Banking and U.S. Venture Partners.
By Stephanie Baum Thursday, October 27, 2022 2:05 PM
The SCOTUS vote to overturn Roe v Wade has drawn greater attention to women's health and health equity. Here's a look at some of the health tech companies addressing this shifting landscape.
By James L. Chen Thursday, October 27, 2022 2:00 PM
Two decentralized clinical trial methodologies that are "low-hanging fruit" include automating data integration for patient trial selection and establishing standardized, electronic clinical trial templates and procedures.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments